**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 105-60-2 |epsilon-Caprolactam | >99 | 203-313-2 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/22 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Irritating to eyes,
respiratory system and skin.Hygroscopic (absorbs moisture from the
air).
Potential Health Effects
Eye:
Causes eye irritation. Vapors cause eye irritation.
Skin:
Causes skin irritation. May cause skin sensitization, an allergic
reaction, which becomes evident upon re-exposure to this material.
May cause dermatitis. May be harmful if absorbed through the skin.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May cause lung damage. May
cause central nervous system effects such as nausea and headache.
Material has a very low vapor pressure and inhalation exposures are
not expected unless material is heated or misted.
Chronic:
Chronic inhalation may cause effects similar to those of acute
inhalation. Animal studies indicate that the product may affect the
liver and kidneys.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid.
Skin:
In case of contact, flush skin with plenty of water. Remove
contaminated clothing and shoes. Get medical aid if irritation
develops and persists. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. This
material in sufficient quantity and reduced particle size is capable
of creating a dust explosion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Wash area with soap and water. Clean up spills
immediately, observing precautions in the Protective Equipment
section. Avoid generating dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid breathing vapors from heated
material. Avoid contact with eyes, skin, and clothing. Avoid
breathing dust. Avoid breathing spray or mist.
Storage:
Store in a cool, dry place. Store in a tightly closed container.
Store protected from moisture. Separate from oxidizing materials.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate general or
local exhaust ventilation to keep airborne concentrations below the
permissible exposure limits.
Exposure Limits
CAS# 105-60-2:
United Kingdom, WEL - TWA: 1 mg/m3 TWA (dust); 10 mg/m3 TWA (dust
vapour)
United Kingdom, WEL - STEL: 3 mg/m3 STEL (dust); 20 mg/m3 STEL (d
and vapour)
Belgium - TWA: 2 ppm VLE (vapor); 1 mg/m3 VLE (dust); 10 mg/m3 VL
(vapor)
Belgium - STEL: 8.7 ppm VLE (vapor); 3 mg/m3 VLE (dust); 40 mg/m3
(vapor)
France - VME: 5 ppm VME (vapor); 20 mg/m3 VME (vapor); 1 mg/m3 VM
(dust)
Germany: 5 mg/m3 TWA (steam and dust, inhalable fraction)
Malaysia: 5 ppm TWA (vapor); 1 mg/m3 TWA (particulate); 23 mg/m3
(vapor)
Netherlands: 5 ppm MAC (fume); 20 mg/m3 MAC (fume); 1 mg/m3 MAC
(dust)
Russia: 10 mg/m3 TWA (dust)
Spain: 10 mg/m3 VLA-ED (dust and vapor)
Spain: 40 mg/m3 VLA-EC (dust and vapor)
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: white
Odor: unpleasant odor
pH: Not available.
Vapor Pressure: 0.0016 mm Hg @ 25 deg C
Viscosity: Not available.
Boiling Point: 268 deg C @ 760 mm Hg
Freezing/Melting Point: 68-71 deg C
Autoignition Temperature: 374 deg C ( 705.20 deg F)
Flash Point: 125 deg C ( 257.00 deg F)
Explosion Limits, lower: 1.40 vol %
Explosion Limits, upper: 8.00 vol %
Decomposition Temperature:
Solubility in water: Soluble.
Specific Gravity/Density: 1.02 @ 75C
Molecular Formula: C6H11NO
Molecular Weight: 113.16
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures. Polymerization of
caprolactam is slow and not violent. It does not occur at < 100C
(212F).
Conditions to Avoid:
Dust generation, moisture, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: May occur.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 105-60-2: CM3675000
LD50/LC50:
CAS# 105-60-2: Draize test, rabbit, eye: 20 mg/24H Moderate; Draize
test, rabbit, skin: 500 mg/24H Mild; Inhalation, mouse: LC50 = 450
mg/m3; Inhalation, rat: LC50 = 300 mg/m3/2H; Oral, mouse: LD50 = 930
mg/kg; Oral, rat: LD50 = 1210 mg/kg; Skin, rabbit: LD50 = 1410
uL/kg; Skin, rat: LD50 = >2 gm/kg.
Carcinogenicity:
epsilon-Caprolactam -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/22 Harmful by inhalation and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
WGK (Water Danger/Protection)
CAS# 105-60-2: 1
Canada
CAS# 105-60-2 is listed on Canada's DSL List.
CAS# 105-60-2 is listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 105-60-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 3/16/1998 Revision #4 Date: 8/13/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Tropylium Hexafluorophosphate
| 29663-54-5 |
|
3-(4-Cyanobenzoyl)-5,7-Dimethoxycoumarin
| 83179-55-9 |
|
Adenine-9-Beta-D-Arabinofuranoside- 5'-Monophosphate, 98%
| 29984-33-6 |
|
4-Tert-Butylaniline, 99%
| 769-92-6 |
|
4,4'-Dicyanobibenzyl
| |
|
Isoquinoline, 99% (GC)
| 119-65-3 |
|
(2-Naphthoxy)Acetic Acid, N-Hydroxysuccinimide Ester, 98%
| 81012-92-2 |
|
Pentafluorophenylhydrazine, 97%
| 828-73-9 |
|
Diphenyl Phosphate, 99%
| 838-85-7 |
|
Manganese(II) bromide tetrahydrate, 98%
| 10031-20-6 |
|
Sulfur trioxide, stabilized, 99%
| 7446-11-9 |
|
epsilon-Caprolactam
| 105-60-2 |
|
2-Bromo-1-Phenylpropane, 98%
| 2114-39-8 |
|
1,1-Bis(Methylseleno)-Ethane
| 56051-04-8 |
|
4-Chloro-2-methylthiopyrimidine, 98%
| 49844-90-8 |
|
4-Cyanobenzoic Acid, 99%
| 619-65-8 |
|
2,2'-Diaminobibenzyl, 96%
| 0-00-1 |
|
(-)-Dihydrocarvyl acetate, mixture of isomers, 99%
| 20777-49-5 |
|
Cyclobutanecarboxylic Acid Chloride, 99%
| 5006-22-4 |
|
4-Methoxybenzylisothiocyanate
| 3694-57-3 |
|
Bis(MSB), scintillation grade, 99.5%
| 13280-61-0 |
|
1-Octene, 97%
| 111-66-0 |
|
Bromoacetaldehyde dimethyl acetal, 97%, stabilized with 0.2%
| 7252-83-7 |
|
d-Histidine hydrochloride monohydrate 99%
| 6341-24-8 |
|
Pimelic acid, 98%
| 111-16-0 |
|
Trans-Beta-Hydromuconic Acid, 98%
| 4436-74-2 |
|
Nickel(ii) acetylacetonate dihydrate, 99+% (titr.)
| 3264-82-2 |
|
Ethyl Allophanate
| 626-36-8 |
|
2,6-Dimethylpyrazine, ca 96% (nmr), balanc e 2,5-isomer
| 108-50-9 |
|
(1,3-Dioxolan-2-ylmethyl)triphenyl phosphonium bromide, 98%
| 52509-14-5 |
|
3,3'-Thiodipropanol, 98%
| 10595-09-2 |
|
2-Imidazolidinethione, paraffinic oil coated powder
| 96-45-7 |
|
Coumarin 7, Laser Grade, 99% (UV-Vis)
| 27425-55-4 |
|
Bemegride, 99+%
| 64-65-3 |
|
DL-3(Methylthio)-2-Butanone 99%
| 53475-15-3 |
|
Methyl (trimethylsilyl)acetate, 98%
| 2916-76-9 |
|
3-Methylindole, 98%
| 83-34-1 |
|
Titanium(IV) isopropoxide, 98+%
| 546-68-9 |
|
2-Hydroxy-4,5-Dimethylacetophenone, 98%
| 36436-65-4 |
|
Allyl sulfide, 97%
| 592-88-1 |
|
Dehydroacetic acid, 98%
| 520-26-3 |
|
Lactulose, 50 Wt% Solution in Water
| 4618-18-2 |
|
Ethylene/propylene copolymer, low molecular weight
| 9010-79-1 |
|
D-(+)-Altrose, 99%
| 1990-29-0 |
|
Ftorafur, 99%
| 17902-23-7 |
|
L(-)-Perillaldehyde, 90% (Titr.)
| 18031-40-8 |
|
3-Amino-5-Methylisoxazole, 98+%
| 1072-67-9 |
|
Yttrium atomic absorption standard solution, 1 mg/ml Y in 2% HNO3
| 7440-65-5 |
|
1,6-Dibromo-2-Naphthol, 99%
| 16239-18-2 |
|
4,4'-Dimethoxytrityl chloride 98%
| 40615-36-9 |
|
|